12 March 2002
Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques.
Helen Zou, Amy Beck, Dave Chervinsky, Weigang Zhu, Debbie Malik, John Brooks, Dongfeng TanMed Sci Monit 2002; 8(3): BR95-99 :: ID: 420892
Abstract
BACKGROUND:A number of molecular changes observed by varied conventionalmethods, including loss of heterozygosity (LOH) on chromosome 3, have been associated with primary lungcancer. To further define the locus of chromosome 3p allele loss in lung cancer, we performed LOH studyby using innovative laser capture microdissection and WAVE DNA Fragment Analysis. MATERIAL/METHODS: Thirty-eightpaired specimens from patients with adenocarcinoma of the lung were used for this study. Formalin-fixed,paraffin-embedded tissue from normal stromal cells or lymphocytes and adenocarcinoma were collected usinglaser capture microdissection. DNA was extracted and amplified by PCR using six polymorphic DNA markersfor chromosome 3. PCR products were analyzed by both gel electrophoresis and WAVE DNA Fragment Analysis.RESULTS: LOH at 3p22-24 was found in tumor cells from twelve out of thirty-eight patients (32%) whenanalyzed by WAVE DNA Fragment Analysis and LOH was found in tumor cells from nine out of thirty-eightpatients (23%) when analyzed by gel electrophoresis. LOH was found in normal control from one out ofthirty-eight patients. CONCLUSIONS: 1. Our results suggest putative tumor suppressor gene(s) is presentin a region at 3p22-24, which may play a role in carcinogenesis of lung cancer. 2. Laser capture microdissectionis essential tool for defined LOH studies. 3. WAVE DNA Fragment Analysis is an accurate, sensitive andautomated tool for analysis of DNA fragments.
Keywords: Aged, 80 and over, Alleles, Chromosomes, Human, Pair 3, DNA Fragmentation, Lasers, Loss of Heterozygosity, Polymerase Chain Reaction, Polymorphism, Genetic, Research Support, Non-U.S. Gov
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952